These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9590246

  • 21. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
    Dong F, Qiu Y, Yi T, Touw IP, Larner AC.
    J Immunol; 2001 Dec 01; 167(11):6447-52. PubMed ID: 11714811
    [Abstract] [Full Text] [Related]

  • 22. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors.
    Sattler M, Salgia R, Shrikhande G, Verma S, Choi JL, Rohrschneider LR, Griffin JD.
    Oncogene; 1997 Nov 06; 15(19):2379-84. PubMed ID: 9393882
    [Abstract] [Full Text] [Related]

  • 23. Distinct region of the granulocyte colony-stimulating factor receptor mediates proliferative signaling through activation of Janus kinase 2 and p44/42 mitogen-activated protein kinase.
    Koay DC, Nguyen T, Sartorelli AC.
    Cell Signal; 2002 Mar 06; 14(3):239-47. PubMed ID: 11812652
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Contribution of the membrane-distal tyrosine in intracellular signaling by the granulocyte colony-stimulating factor receptor.
    Kendrick TS, Lipscombe RJ, Rausch O, Nicholson SE, Layton JE, Goldie-Cregan LC, Bogoyevitch MA.
    J Biol Chem; 2004 Jan 02; 279(1):326-40. PubMed ID: 14557262
    [Abstract] [Full Text] [Related]

  • 26. Advances in understanding postreceptor signaling in response to granulocyte colony-stimulating factor.
    Tidow N, Welte K.
    Curr Opin Hematol; 1997 May 02; 4(3):171-5. PubMed ID: 9209832
    [Abstract] [Full Text] [Related]

  • 27. Swapping between Fas and granulocyte colony-stimulating factor receptor.
    Takahashi T, Tanaka M, Ogasawara J, Suda T, Murakami H, Nagata S.
    J Biol Chem; 1996 Jul 19; 271(29):17555-60. PubMed ID: 8663376
    [Abstract] [Full Text] [Related]

  • 28. Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor.
    Yoshikawa A, Murakami H, Nagata S.
    EMBO J; 1995 Nov 01; 14(21):5288-96. PubMed ID: 7489718
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Regulation of hematopoietic cell signaling by SHIP-1 inositol phosphatase: growth factors and beyond.
    Hibbs ML, Raftery AL, Tsantikos E.
    Growth Factors; 2018 Dec 01; 36(5-6):213-231. PubMed ID: 30764683
    [Abstract] [Full Text] [Related]

  • 31. Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction.
    Ziegler SF, Bird TA, Morella KK, Mosley B, Gearing DP, Baumann H.
    Mol Cell Biol; 1993 Apr 01; 13(4):2384-90. PubMed ID: 7681146
    [Abstract] [Full Text] [Related]

  • 32. Multiple signals mediate proliferation, differentiation, and survival from the granulocyte colony-stimulating factor receptor in myeloid 32D cells.
    Ward AC, Smith L, de Koning JP, van Aesch Y, Touw IP.
    J Biol Chem; 1999 May 21; 274(21):14956-62. PubMed ID: 10329697
    [Abstract] [Full Text] [Related]

  • 33. Altered expression of CSF3R splice variants impacts signal response and is associated with SRSF2 mutations.
    Lance A, Druhan LJ, Vestal CG, Steuerwald NM, Hamilton A, Smith M, Price A, Tjaden E, Fox AN, Avalos BR.
    Leukemia; 2020 Feb 21; 34(2):369-379. PubMed ID: 31462738
    [Abstract] [Full Text] [Related]

  • 34. Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury.
    Liska MG, Dela Peña I.
    Brain Circ; 2017 Feb 21; 3(3):143-151. PubMed ID: 30276316
    [Abstract] [Full Text] [Related]

  • 35. Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease.
    Tsantikos E, Lau M, Castelino CM, Maxwell MJ, Passey SL, Hansen MJ, McGregor NE, Sims NA, Steinfort DP, Irving LB, Anderson GP, Hibbs ML.
    J Clin Invest; 2018 Jun 01; 128(6):2406-2418. PubMed ID: 29708507
    [Abstract] [Full Text] [Related]

  • 36. Enhanced MAPK signaling is essential for CSF3R-induced leukemia.
    Rohrabaugh S, Kesarwani M, Kincaid Z, Huber E, Leddonne J, Siddiqui Z, Khalifa Y, Komurov K, Grimes HL, Azam M.
    Leukemia; 2017 Aug 01; 31(8):1770-1778. PubMed ID: 28031554
    [Abstract] [Full Text] [Related]

  • 37. Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.
    Liongue C, Ward AC.
    Front Oncol; 2014 Aug 01; 4():93. PubMed ID: 24822171
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.
    Blunt MD, Ward SG.
    Front Immunol; 2012 Aug 01; 3():226. PubMed ID: 22876243
    [Abstract] [Full Text] [Related]

  • 39. New role for granulocyte colony-stimulating factor-induced extracellular signal-regulated kinase 1/2 in histone modification and retinoic acid receptor α recruitment to gene promoters: relevance to acute promyelocytic leukemia cell differentiation.
    Cassinat B, Zassadowski F, Ferry C, Llopis L, Bruck N, Lainey E, Duong V, Cras A, Despouy G, Chourbagi O, Beinse G, Fenaux P, Rochette Egly C, Chomienne C.
    Mol Cell Biol; 2011 Apr 01; 31(7):1409-18. PubMed ID: 21262770
    [Abstract] [Full Text] [Related]

  • 40. Growth factors in ischemic stroke.
    Lanfranconi S, Locatelli F, Corti S, Candelise L, Comi GP, Baron PL, Strazzer S, Bresolin N, Bersano A.
    J Cell Mol Med; 2011 Aug 01; 15(8):1645-87. PubMed ID: 20015202
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.